why choose us

First received: July 17, 2023

Clinical Trial: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Bradycardia

Study Type: INTERVENTIONAL


Official Title: BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family

Brief Summary: The study is designed as an open-label, prospective, international, multicenter, non-randomized study to determine safety and product performance of the CE-marked Amvia/Solvia pacemaker family, including the aATP, CRT AutoAdapt and Early Check features in the setting of a post-market clinical follow-up study.

Read more